We are live on
!
Find out more
AQR Capital Management Portfolio holdings
AUM
$218B
1-Year Est. Return
29.41%
This Fund
S&P 500
This Quarter
Est. Return
+12.21%
1 Year Est. Return
+29.41%
3 Year Est. Return
+92.15%
5 Year Est. Return
+116.61%
10 Year Est. Return
+435.72%
AUM
$53.1B
AUM Growth
+$4.7B
(+9.7%)
Cap. Flow
-$415M
Cap. Flow
% of AUM
-0.78%
Top 10 Holdings %
Top 10 Hldgs %
15.39%
Holding
2,495
New
186
Increased
937
Reduced
1,188
Closed
172
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$144M |
| 2 |
NVIDIA
NVDA
|
+$137M |
| 3 |
GE Aerospace
GE
|
+$129M |
| 4 |
Dell
DELL
|
+$91.3M |
| 5 |
Comcast
CMCSA
|
+$88.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$103M |
| 2 |
Microchip Technology
MCHP
|
+$98.3M |
| 3 |
Steel Dynamics
STLD
|
+$87M |
| 4 |
UnitedHealth
UNH
|
+$79.5M |
| 5 |
Walmart Inc
WMT
|
+$79.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.58% |
| 2 | Consumer Discretionary | 13.58% |
| 3 | Healthcare | 12.97% |
| 4 | Financials | 12.15% |
| 5 | Industrials | 12.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1976
DigitalBridge
DBRG
$2.95B
| $392K | ﹤0.01% |
22,346
+12,025
| +117% | +$198K |
|
1977
MoonLake Immunotherapeutics
MLTX
$1.47B
| $392K | ﹤0.01% |
+6,488
| New | +$334K |
|
|
AKRO
1978
DELISTED
Akero Therapeutics
AKRO
| $392K | ﹤0.01% |
16,767
+5,868
| +54% | +$116K |
|
1979
RCI Hospitality Holdings
RICK
$207M
| $391K | ﹤0.01% |
5,896
-2,954
| -33% | -$172K |
|
1980
UFP Technologies
UFPT
$2.52B
| $390K | ﹤0.01% |
2,267
-696
| -23% | -$113K |
|
1981
Novanta
NOVT
$6.2B
| $389K | ﹤0.01% |
2,310
-3,148
| -58% | -$459K |
|
1982
Dimensional World ex US Core Equity 2 ETF
DFAX
$12.4B
| $389K | ﹤0.01% |
+15,912
| New | +$364K |
|
1983
Suzano
SUZ
$10B
| $383K | ﹤0.01% |
33,708
-163
| -0.5% | -$1.76K |
|
1984
Alcoa
AA
$13.6B
| $383K | ﹤0.01% |
11,262
+3,219
| +40% | +$87.1K |
|
1985
J&J Snack Foods
JJSF
$1.68B
| $382K | ﹤0.01% |
2,288
-687
| -23% | -$112K |
|
1986
Apple Hospitality REIT
APLE
$3.71B
| $382K | ﹤0.01% |
23,015
-49,011
| -68% | -$796K |
|
|
AGEN
1987
Agenus
AGEN
$315M
| $382K | ﹤0.01% |
+23,079
| New | +$382K |
|
1988
iShares MSCI France ETF
EWQ
$334M
| $381K | ﹤0.01% |
+9,737
| New | +$356K |
|
1989
Fulton Financial
FULT
$4.6B
| $381K | ﹤0.01% |
23,165
-710,118
| -97% | -$9.97M |
|
1990
Mirum Pharmaceuticals
MIRM
$6.02B
| $380K | ﹤0.01% |
12,876
-2,667
| -17% | -$80.7K |
|
|
VGR
1991
DELISTED
Vector Group Ltd.
VGR
| $380K | ﹤0.01% |
33,682
-5,145
| -13% | -$55.8K |
|
1992
Byline Bancorp
BY
$1.75B
| $380K | ﹤0.01% |
16,109
-1,739
| -10% | -$36K |
|
1993
Cameco
CCJ
$42.4B
| $377K | ﹤0.01% |
8,742
-1,217
| -12% | -$50.9K |
|
|
UDMY
1994
DELISTED
Udemy
UDMY
| $375K | ﹤0.01% |
25,458
+15,237
| +149% | +$190K |
|
1995
Liquidia Corp
LQDA
$8.1B
| $375K | ﹤0.01% |
31,148
-1,434
| -4% | -$10.3K |
|
1996
Kontoor Brands
KTB
$4.27B
| $371K | ﹤0.01% |
5,944
-2,901
| -33% | -$149K |
|
1997
Vanguard High Dividend Yield ETF
VYM
$83.7B
| $370K | ﹤0.01% |
+3,315
| New | +$348K |
|
1998
Unity
U
$19B
| $370K | ﹤0.01% |
+9,038
| New | +$279K |
|
1999
GoodRx Holdings
GDRX
$1.25B
| $369K | ﹤0.01% |
+55,011
| New | +$310K |
|
2000
Red Robin
RRGB
$150M
| $367K | ﹤0.01% |
29,397
+15,736
| +115% | +$147K |
|
Similar funds
VGA
AQR Capital Management's Q4 2023 Portfolio in Review
As of Q4 2023, AQR Capital Management held 2,495 positions worth $53.1B, up 9.7% from $48.4B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
AQR Capital Management's Q4 2023 filing shows 186 new, 937 increased, 1,188 reduced and 172 closed positions. Its largest new stake was NCR Atleos: 518,383 shares worth $12.5M. The largest sale was Pfizer, an estimated $103M.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 23% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- AQR Capital Management's largest Q4 2023 buy was NCR Atleos: 518,383 shares worth $12.5M.
- AQR Capital Management added most to Amazon in Q4 2023, an estimated $144M increase.
- AQR Capital Management's biggest Q4 2023 reduction was Pfizer, cutting an estimated $103M.
- AQR Capital Management fully exited Activision Blizzard in Q4 2023, selling an estimated $38.5M.
- AQR Capital Management's ten largest holdings make up 15% of its $53.1B portfolio in Q4 2023.
- AQR Capital Management opened 186 new positions and closed 172 in Q4 2023.
- AQR Capital Management's portfolio value rose 9.7% quarter-over-quarter to $53.1B.
Based on AQR Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.